JP2019089829A5 - - Google Patents

Download PDF

Info

Publication number
JP2019089829A5
JP2019089829A5 JP2019023946A JP2019023946A JP2019089829A5 JP 2019089829 A5 JP2019089829 A5 JP 2019089829A5 JP 2019023946 A JP2019023946 A JP 2019023946A JP 2019023946 A JP2019023946 A JP 2019023946A JP 2019089829 A5 JP2019089829 A5 JP 2019089829A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pharmaceutically acceptable
compound
crystal
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019023946A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019089829A (ja
JP6738918B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019089829A publication Critical patent/JP2019089829A/ja
Publication of JP2019089829A5 publication Critical patent/JP2019089829A5/ja
Application granted granted Critical
Publication of JP6738918B2 publication Critical patent/JP6738918B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019023946A 2013-03-15 2019-02-13 メロペネム誘導体及びその製造法 Expired - Fee Related JP6738918B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361789335P 2013-03-15 2013-03-15
US61/789,335 2013-03-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016502851A Division JP2016517435A (ja) 2013-03-15 2014-03-14 メロペネム誘導体及びその使用

Publications (3)

Publication Number Publication Date
JP2019089829A JP2019089829A (ja) 2019-06-13
JP2019089829A5 true JP2019089829A5 (https=) 2019-08-08
JP6738918B2 JP6738918B2 (ja) 2020-08-12

Family

ID=51537664

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016502851A Ceased JP2016517435A (ja) 2013-03-15 2014-03-14 メロペネム誘導体及びその使用
JP2019023946A Expired - Fee Related JP6738918B2 (ja) 2013-03-15 2019-02-13 メロペネム誘導体及びその製造法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016502851A Ceased JP2016517435A (ja) 2013-03-15 2014-03-14 メロペネム誘導体及びその使用

Country Status (8)

Country Link
US (4) US9725451B2 (https=)
EP (1) EP2968274B1 (https=)
JP (2) JP2016517435A (https=)
AU (2) AU2014227737B2 (https=)
BR (1) BR112015023621A8 (https=)
CA (1) CA2906689A1 (https=)
HK (1) HK1219233A1 (https=)
WO (1) WO2014144285A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111362239B (zh) * 2020-03-20 2021-07-06 辽宁瑞鸥新材料科技有限公司 一种用于铝硅系合金半固态制浆的Cs2HPO4气溶胶及其使用方法
CN112076161B (zh) * 2020-08-07 2022-10-18 安徽康正康仁药业有限公司 一种头孢菌素类钠盐与丙磺舒钠组成的复方冻干制剂
US11793808B2 (en) 2021-02-22 2023-10-24 Mannkind Corp. Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
CA3216616A1 (en) * 2021-04-27 2022-11-03 Philip V. Felice Compositions comprising cocrystals of acetylsalicylic acid and theanine with tromethamine and methods of use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM884A1 (en) * 1983-01-28 1984-10-22 Bristol Myers Co Substituted vinyl cephalosporins
EP0130119B1 (en) * 1983-06-23 1988-11-09 Merck & Co. Inc. (acyloxyalkoxy) carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs, their preparation and pharmaceutical compositions containing said derivatives
US4914091A (en) 1984-04-02 1990-04-03 American Cyanamid Company Esters of cephalosporin derivitives
JPS6247874A (ja) 1985-08-27 1987-03-02 Sankyo Seiki Mfg Co Ltd プログラム動作装置の初期化方法
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
JPH06192273A (ja) * 1992-10-26 1994-07-12 Lederle Japan Ltd カルバペネム−3−カルボン酸エステル誘導体
WO1997049387A1 (en) * 1996-06-27 1997-12-31 G.D. Searle And Co. Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
TR200003199T2 (tr) 1998-05-01 2001-03-21 Kyoto Pharmaceutical Industries, Ltd. Karbapenem türevleri, bunların kullanımı ve ara birleşiği
JP2000344773A (ja) * 1998-07-17 2000-12-12 Kyoto Pharmaceutical Industries Ltd カルバペネム誘導体、およびその用途並びにその中間体化合物
JP2000344772A (ja) 1998-05-01 2000-12-12 Kyoto Pharmaceutical Industries Ltd カルバペネム誘導体、その用途およびその中間体化合物
JP2000344774A (ja) * 1999-06-03 2000-12-12 Meiji Seika Kaisha Ltd カルバペネム類の製造法
KR20040000466A (ko) * 2001-05-21 2004-01-03 교토 야쿠힝 고교 가부시키가이샤 카르바페넴 화합물
US20050065141A1 (en) * 2003-07-31 2005-03-24 Odink Debra A. Carbapenems useful in treating and preventing pulmonary infections, pharmaceutical compositions thereof and modes of administration thereof
EP2085084A1 (en) * 2008-01-29 2009-08-05 LEK Pharmaceuticals D.D. Use of inhibitor of beta-lactamases and its combination with beta-lactam antibiotics
PH12013500954A1 (en) * 2010-11-11 2017-05-19 Redx Pharma Plc Drug derivatives
NZ722096A (en) * 2011-12-15 2016-11-25 Alkermes Pharma Ireland Ltd Prodrugs of secondary amine compounds
NZ742005A (en) 2012-05-03 2019-04-26 Kala Pharmaceuticals Inc Pharmaceutical nanoparticles showing improved mucosal transport

Similar Documents

Publication Publication Date Title
JP2019089829A5 (https=)
JP5774732B2 (ja) モキシフロキサシン塩酸塩の合成方法
US20080044466A1 (en) Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment
WO2018149359A1 (zh) 三氮唑抗菌衍生物、其药物组合物和用途
HU229935B1 (en) Dual action antibiotics
CN105452259A (zh) 三环苯并氧杂硼化合物、其制备方法与应用
JP2008519788A5 (https=)
US9840467B2 (en) Arylhydrazides containing a 2-pyridone moiety as selective antibacterial agents
JP2002505328A (ja) 抗潰瘍医薬の硝酸塩
JP2010517983A5 (https=)
JPWO2022076625A5 (https=)
SK282545B6 (sk) Kryštalické adičné soli cefému s kyselinami, spôsob ich výroby, ich použitie a liečivo s ich obsahom
WO2015098693A1 (ja) ピリドンカルボン酸系抗菌薬のアルコキシカルボニルヘミアセタール型エステルプロドラッグ
JP2018510189A5 (https=)
JP6077725B1 (ja) 呼吸器感染症治療剤
JP2019524829A5 (https=)
CA2537066C (en) Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
CN104098588B (zh) 一类三环喹诺酮衍生物及其制备方法和用途
WO2011121596A2 (en) Crystal modification of moxifloxacin hydrochloride
JP7645874B2 (ja) シデロフォア・セファロスポリン・コンジュゲートおよびその使用
JP6402120B2 (ja) グラム陽性病原菌に対する活性のある新規の1,2,4−オキサジアゾール化合物
CN115066417A (zh) 凝血因子XIa抑制剂
JP2002507616A5 (https=)
CN102040615B (zh) 含有二氢吡咯并环烷基的头孢抗生素
CN1449384A (zh) 新颖的酯或酰胺衍生物